What is Sutro Biopharma, Inc.'s Market Cap?

Sutro Biopharma, Inc.'s Market Cap is $154.7M, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s Price / Sales?

Sutro Biopharma, Inc.'s Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s Revenue (TTM)?

Sutro Biopharma, Inc.'s Revenue (TTM) is $45.7M, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s Net Income (TTM)?

Sutro Biopharma, Inc.'s Net Income (TTM) is -$180.6M, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s EBITDA?

Sutro Biopharma, Inc.'s EBITDA is -$140.0M, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s Diluted EPS (TTM)?

Sutro Biopharma, Inc.'s Diluted EPS (TTM) is -10.89, based on as-reported figures from SEC (XBRL) filings.

What is Sutro Biopharma, Inc.'s EBITDA Margin?

Sutro Biopharma, Inc.'s EBITDA Margin is -306.3%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Sutro Biopharma, Inc.

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001T94MP6

9.33▼ 0.96 (-9.33%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value: —
Trailing P/E: —
Price / Sales
EV / Revenue: —
EV / EBITDA: —

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt: —

Trading Information

Previous Close: 10.29
Day's Range: 9.16 – 10.29
52-Week Range: 0.72 – 43.85
Volume: 427.4K
Avg Volume: 340.9K

Share Statistics

Shares Outstanding
Employees: 137
Exchange: XNAS
Listed: 2018-09-27

Share count as of August 7, 2026

Sutro Biopharma, Inc. (STRO) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Sutro Biopharma, Inc. (STRO)

What is Sutro Biopharma, Inc.'s Market Cap?: Sutro Biopharma, Inc.'s Market Cap is $154.7M, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s Price / Sales?: Sutro Biopharma, Inc.'s Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s Revenue (TTM)?: Sutro Biopharma, Inc.'s Revenue (TTM) is $45.7M, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s Net Income (TTM)?: Sutro Biopharma, Inc.'s Net Income (TTM) is -$180.6M, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s EBITDA?: Sutro Biopharma, Inc.'s EBITDA is -$140.0M, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s Diluted EPS (TTM)?: Sutro Biopharma, Inc.'s Diluted EPS (TTM) is -10.89, based on as-reported figures from SEC (XBRL) filings.
What is Sutro Biopharma, Inc.'s EBITDA Margin?: Sutro Biopharma, Inc.'s EBITDA Margin is -306.3%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · STROAs-filed SEC (XBRL) data